INOTIV INC. - COMMON

Inotiv, Inc. Announces Fourth Quarter and Full Year Fiscal 2021 Financial Results

16 Dec 2021 16:05:00 By Nasdaq GlobeNewswire

Inotiv, Inc. Reschedules Fourth Quarter Fiscal 2021 Financial Results and Conference Call for Thursday, December 16, 2021

13 Dec 2021 16:05:00 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces the Launch of New Genetically Engineered Rodent Models for SARS-CoV-2 (COVID-19) Research

13 Dec 2021 08:33:00 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces Select Preliminary Unaudited Financial Results for the Fourth Quarter and Full Year Fiscal 2021

07 Dec 2021 16:03:00 By Nasdaq GlobeNewswire

Inotiv, Inc. to Report Fourth Quarter Fiscal 2021 Financial Results and Host Conference Call on Tuesday, December 7, 2021

29 Nov 2021 16:21:00 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces Opening of Newly-Constructed Laboratories at St. Louis Facility

10 Nov 2021 08:33:00 By Nasdaq GlobeNewswire

Inotiv, Inc. Completes Purchase of Envigo

05 Nov 2021 13:33:34 By Nasdaq GlobeNewswire

Inotiv, Inc. Shareholders Approve Acquisition of Envigo

04 Nov 2021 12:00:00 By Nasdaq GlobeNewswire

Inotiv, Inc. to Participate in Upcoming Investor Conferences

02 Nov 2021 17:34:47 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces Expansion of In Vivo Pharmacology Offering with Acquisition of Plato BioPharma, Inc.

04 Oct 2021 16:05:00 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces Closing of $125 Million Convertible Senior Notes Offering and Full Exercise of Option to Purchase Additional $15 Million of Notes

27 Sep 2021 16:05:00 By Nasdaq GlobeNewswire

Inotiv, Inc. Prices Upsized $125 Million Convertible Senior Notes Offering

22 Sep 2021 18:34:29 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces Proposed Convertible Senior Notes Offering

21 Sep 2021 17:05:00 By Nasdaq GlobeNewswire

Inotiv, Inc. and Envigo Propose to Join Forces to Enhance Research and Drug Discovery Solutions

21 Sep 2021 09:00:02 By Nasdaq GlobeNewswire

Inotiv, Inc. to Participate in the 2021 Colliers Institutional Investor Conference

31 Aug 2021 16:05:00 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces Third Quarter Fiscal 2021 Financial Results

11 Aug 2021 16:05:01 By Nasdaq GlobeNewswire

Inotiv, Inc. Announces Acquisition of Gateway Pharmacology Laboratories

02 Aug 2021 12:15:00 By Nasdaq GlobeNewswire

Inotiv, Inc. to Report Third Quarter Fiscal 2021 Financial Results and Host Conference Call on Wednesday, August 11, 2021

22 Jul 2021 16:05:01 By Nasdaq GlobeNewswire

Inotiv Acquires Laboratory Instrumentation for Discovery and Development of Novel Therapies

15 Jul 2021 08:33:00 By Nasdaq GlobeNewswire

Inotiv Acquires Genetic Toxicology Assets from MilliporeSigma’s BioReliance® portfolio

12 Jul 2021 08:33:00 By Nasdaq GlobeNewswire